neublastin
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2009 (NCT00961766)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bg00010
- neublastin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01873404 | Phase 2 | Jun 1, 2013 | Biogen |
| NCT01842126 | Phase 1 | Apr 1, 2013 | Biogen |
| NCT01405833 | Phase 1 | Jul 1, 2011 | Biogen |
| NCT00961766 | Phase 1 | Aug 1, 2009 | Biogen |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biogen | For profit | 4 | 4 | 2 | 2009 |
1 organizations
Page 1 / 1